Healthcare ETF: China May Control a Key Bottleneck in AI Drug Discovery

Healthcare ETF: Treatment Breakthroughs Make China A Medical Destination

Healthcare ETF: Outbound Biotech Licensing As Potential New Growth Driver In China

KURE

KURE: Capitalizing on China’s Healthcare Revolution

New Drivers For China Healthcare: AI Med-Tech Innovation, Cancer Treatment, & Favorable Balance of Trade

By Henry Greene, Investment Strategist

Outlook Healthier For Key Chinese Sector

By Anthony Sassine, CFA and Henry Greene

China Health Care: A Rediscovered Sector Keeps Its Momentum